Name: | Silymarin | Synonyms: | Silybum Marianum;silybin Or Silybinin;MilkthistleP.E.exsemencardui;Milkthistleextract/Silymarin;Milkthistleseedextract,powder=Silymarin/Silybin;Silybummarianumextract,seed |
---|---|---|---|
CAS No: | 65666-07-1 | EINECS No: | 613-830-9 |
Molecular Formula: | C25H22O10 | Molecular Weight: | 482.44 |
Melting Point: | 158 °C | ||
High Light: | milk thistle 80 silymarin powder,pure silymarin powder,milk thistle extract powder |
Silymarin; CAS 65666-07-1; Extract; Cosmetic/ Pharmaceutical
Name | Silymarin |
Synonyms | Silybum marianum;silybin or silybinin;.exsemencardui;Milkthistleextract/Silymarinn;Silybummarianumextract,seed |
Molecular Formula | C25H22O10 |
Molecular Weight | 482.44 |
CAS Registry Number | 65666-07-1 |
EINECS Number | 613-830-9 |
Melting point | 158 °C |
Product Description:
Silymarin is a kind of flavonoid complex consisting of silybin, silydianin, and silychrisin, derived from the milk thistle plant. It is a kind of potent antioxidant, anti-cancer agent as well as liver protecting agent. It has a lot of pharmaceutical functions.
For example:
(1) Promotes healthy liver function and general health;
(2) Strengthen the normal cellular defense system to protect the liver tissue;
(3) Help to eliminate the toxin accumulating in the liver;
(4) Increase the survival rate of patients of cirrhosis;
(5) Protect our body against industrial poisons;
(6) Antidote against the death cap mushroom. Silymarin exerts its pharmaceutical effects through various mechanism including scavenging free radicals, increasing glutathione (has detoxifying effect) level in the liver, increasing the levels of antioxidant enzymes such as superoxide dismutase, stimulating liver protein synthesis and inhibiting the synthesis of leukotrienes.
Product Use:
In the United States, milk thistle is most commonly used to treat viral infections and cirrhosis of the liver. Milk thistle (Silybum marianum) was used in classical Greece to treat liver and gallbladder diseases and to protect the liver against toxins. It recently has been investigated for use as a cytoprotectant, an anticarcinogen, and a supportive treatment for liver damage from Amanita phalloides poisoning. Its active ingredient is silymarin, found primarily in the seeds. Silymarin undergoes enterohepatic recirculation, which results in higher concentrations in liver cells than in serum.It is made up of components called flavonolignans, the most common being silybin.
Number | Cas | Name |
1 | 62-46-4 | Alpha Lipoic Acid |
2 | 303-98-0 | Coenzyme Q10 |
3 | 6020-87-7 | Creatine Monohydrate |
4 | 110-17-8 | Fumaric Acid |
5 | 3416-24-8 | Glucosamine |
6 | 87-89-8 | Inositol |
7 | 73-22-3 | L-Tryptophan |
8 | 56-87-1 | L-Lysine |
9 | 24634-61-5 | Potassium Sorbate |
10 | 56038-13-2 | Sucralose |
11 | 107-35-7 | Taurine |
12 | 128-13-2 | Ursodeoxycholic Acid/ UDCA |
13 | 59-43-8 | Vitamin B1 |
14 | 83-88-5 | Vitamin B2 |
15 | 8059-24-310 | Vitamin B6 |
16 | 68-19-9 | Vitamin B12 |
17 | 50-81-7 | Vitamin C |
18 | 1406-18-4 | Vitamin E |
19 | 11138-66-2 | Xanthan Gum |
About us
Zhejiang chemical import and export co., LTD. (zhejiang), formerly known as zhejiang branch of China national chemical import and export corporation, was established in December 1980. In 1988, he was transferred from Sinochem Corporation to be in charge of Zhejiang Provincial Department of Commerce and was renamed Zhejiang Chemical Import and Export Company. In 2003, the company changed its name to Zhejiang Chemical Import and Export Co., Ltd after the reform of state-owned enterprise shareholding system.
In 2008, it was incorporated into Zhejiang International Trade Group (one of the top 500 enterprises in China) and became the core member of the group's business circulation sector. The registered capital of the company is 72.5 million yuan, of which 38% are owned by the state and 62% are owned by employees.
There are 195 employees in the company, more than 79% of whom have bachelor's degree, 36% of whom are graduate students, and more than 90% of the salesmen have pharmaceutical and chemical background. The company is mainly engaged in the import and export trade of pharmaceutical raw materials and intermediates, dyes, pesticides, basic chemicals, fine chemicals, food and feed additives, pharmaceutical preparations and other products. The company has established close economic and trade relations with more than 100 countries and regions around the world. The company has wholly-owned subsidiaries Ruike International Trade Co., Ltd., Zhejiang Ruikai Chemical Co., Ltd., Zhejiang Fukai Import and Export Co., Ltd., joint-stock enterprise Zhejiang Aotokang Pharmaceutical Group Co., Ltd.
In recent years, especially since the establishment of the new team in 2019, the company has adhered to the development led by the party building, energized by reform, and improved efficiency by management. The company has shown a steady upward momentum of development. In 2020, the company achieved revenue of 3.337 billion yuan, total profit of 56.12 million yuan, total import and export of 450 million dollars.
In 2019, the company was rated as China Council for the Promotion of International Trade (CCPIT) Recommended Certification Enterprise, Top 100 International Pharmaceutical Enterprises -- a high-quality supplier and partner in the international market; In 2020, Zhejiang Provincial Department of Commerce and other units rated as the province's epidemic prevention and medical materials import outstanding contribution enterprise, Zhejiang Provincial Tax Bureau identified as the export tax rebate enterprises.